Skip to main content
. 2017 Jul;20(7):753–759. doi: 10.22038/IJBMS.2017.9005

Figure 5.

Figure 5

Tissue malondialdehyde (MDA) and ferric reducing/antioxidant power (FRAP) levels per g kidney weight at the end of the reperfusion period in rats which underwent renal ischemia/reperfusion (I/R) and those treated with zero (I/R), 100, 200, or 400 mg/kg of crocin (I/R+C) compared to the sham group. Data are presented as mean±SE (n=7)

*P<0.05; **P<0.01; ***P<0.001 in comparison with the sham group. ‡‡P<0.01; ‡‡‡P<0.001 in comparison with the I/R group